Sci Rep 15 , 32385 (2025)
Subsequent increases of 2.5 mg occur every four weeks as tolerated, up to a maximum of 15 mg per week
[,] This systematic review aimed to analyze clinical trial data regarding the efficacy and safety of GLP-1 in the management of GDM and to assess the current evidence on the safety and efficacy of GLP-1 receptor agonists as pharmacologic options for managing GDM, based on available clinical trial data
The Bottom Line For many patients with thyroid conditions, GLP-1 medications can be used safely and effectively when guided by evidence and proper monitoring
We hope that through reviewing the potential mechanism of depression in GD, more attention can be drawn to the prevention and treatment of psychiatric complications of GD, so as to improve the treatment and prognosis of the disease
Licensed clinicians can prescribe it through compounded pharmacies where permitted